Resnik, David B. and Tinkle, Sally S. (2007) Ethical issues in clinical trials involving nanomedicine. CONTEMPORARY CLINICAL TRIALS, 28 (4). pp. 433-441.
Full text is not hosted in this archive but may be available via the Official URL, or by requesting a copy from the corresponding author.
Official URL: http://www.sciencedirect.com/science?_ob=ArticleUR...
Nanomedicine shows tremendous promise for improving medical diagnosis, treatment, and prevention, but it also raises a variety of ethical concerns. Because of the paucity of data on the physicochemical properties of nanoscale materials in biological systems, clinical trials of nanomedicine products present some unique challenges related to risk minimization, management and communication involving human subjects. Although these clinical trials do not raise any truly novel ethical issues, the rapid development of nanotechnology and its potentially profound social and environmental impacts, add a sense of urgency to the problems that arise. (c) 2006 Elsevier Inc. All rights reserved.
|Uncontrolled Keywords:||nanomedicine; nanotechnology; ethics; clinical trials|
|Subjects:||Social and Political Science > Societal and ethical aspects of nanotechnology|
Biomedical Science > Nanomedicine
|Deposited By:||INVALID USER|
|Deposited On:||04 Dec 2008 17:07|
|Last Modified:||05 Jan 2009 17:14|
Repository Staff Only: item control page